[Federal Register Volume 82, Number 37 (Monday, February 27, 2017)]
[Notices]
[Pages 11950-11951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03733]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The U.S. Nuclear Regulatory Commission will convene a meeting of 
the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 
26-27, 2017. A sample of agenda items to be discussed during the public 
session includes: (1) An update on medical-related events; (2) a 
presentation by Elekta on the physical presence requirements for the 
Leksell Gamma Knife[supreg] IconTM; (3) an update on 
Category 3 source security and accountability evaluation initiatives; 
(4) a discussion on the training and experience requirements for 
authorized individuals for various modalities; (5) an update on the 
patient release project; (6) a discussion on the reporting of medical 
events for various modalities; (7) a discussion on patient 
intervention; and (8) a discussion on medical event reporting and 
impact on safety culture. The agenda is subject to change. The current 
agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2017.html or by emailing Ms. Michelle 
Smethers at the contact information below.
    Purpose: Discuss issues related to title 10 of the Code of Federal 
Regulations (10 CFR) Part 35 Medical Use of Byproduct Material.
    Date and Time for Open Sessions: April 26, 2017, from 8:00 a.m. to 
2:30 p.m. and April 27, 2017, from 8:00 a.m. to 3:45 p.m.
    Date and Time for Closed Sessions: April 26, 2017, from 7:30 a.m. 
to 8:00 a.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.

PUBLIC PARTICIPATION: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Smethers using the information below. The meeting will also be webcast 
live: https://video.nrc.gov/.

CONTACT INFORMATION: Michelle Smethers, email: 
[email protected], telephone: (301) 415-0168.

[[Page 11951]]

Conduct of the Meeting

    Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Smethers using the contact information listed 
above. All submittals must be received by April 21, 2017, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2017.html on or about June 14, 2017.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Smethers of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated at Rockville, Maryland, this 21st day of February, 2017.

    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2017-03733 Filed 2-24-17; 8:45 am]
 BILLING CODE 7590-01-P